CHARGED ALPHATMFrontier AI stock research

NEOG · NasdaqGS

Neogen Corporation

Medical Devices · United States

USD 13.001.3% daily changeQuote 2026-09-18 · USD
Market cap (USD)
US$2.84B
Trailing P/E
Forward P/E
34.21x
Quarterly revenue growth
-0.1%
Trailing net margin
-0.9%
Indicated dividend yield

Snapshot 2026-09-20 · Latest financial period 2026-05-31 · Yahoo Finance. Quotes may be delayed; reporting periods can differ.

Next earnings: 2026-10-06 (provider estimate, not issuer-confirmed).

Company background

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Company website

Q4 FY2026

Go beyond the headline.

Neogen (NEOG): Revenue Fell, It Lost Money, and the Stock Jumped 28% — Is NEOG Stock a Buy?

Published 2026-08-01

Comparable businesses

NEOG peer comparison

Same business group first, then company size. Preferred market cap: 0.5–2x; extended range: one-third–3x. Outside that range, industry benchmarks are labeled separately and excluded from peer medians.

Comparison stocks

No suitable peers with fresh, comparable size data are available. We have not substituted unrelated companies.

Market metrics · missing or inapplicable values shown as —
MetricNEOGNeogen CorporationSnapshot 2026-09-20Financial period: 2026-05-31
Market capMarket value, converted to USDUS$2.84B
Forward P/EProvider forward earnings estimate34.21x
EV / EBITDAEnterprise value / trailing EBITDA36.56x
Revenue growthLatest quarter vs prior-year quarter-0.1%
Operating marginLatest reported quarter1.4%
Free cash flow yieldTrailing cash flow / market cap2.5%
Net debt / EBITDANet debt / trailing EBITDA6.62x
Debt / equityTotal debt / positive book equity0.39x
Trailing P/ETrailing twelve-month earnings
Price / bookPrice / positive book equity per share1.35x
EV / salesEnterprise value / trailing revenue3.98x
Earnings growthLatest quarter vs prior-year quarter
Gross marginTrailing twelve months46.9%
Net marginTrailing twelve months-0.9%
Return on equityProvider trailing return; positive equity only-0.4%
Free cash flow marginTrailing free cash flow / revenue8.0%
Dividend yieldIndicated annual dividend / price
Earnings payoutProvider trailing dividend payout0.0%
Current ratioCurrent assets / current liabilities3.82x
BetaProvider historical market sensitivity1.76

Choose a comparison stock

Search covered companies, or search all listed stocks.

Comparison methodology & limitations

Reviewed operating groups override broad sector classifications. Other companies are matched only within a sufficiently specific provider industry. Business mix, geography and accounting standards can still differ. Market caps are converted to USD using exchange rates captured during the snapshot refresh. Financial ratios that would mix currencies are omitted. Snapshots must be at most 14 days old and no more than seven days apart for automatic selection.

Peer medians require at least two valid similar-size peers for each metric. Negative earnings, nonpositive equity, missing data and irrelevant bank ratios are not presented as attractive valuations. A higher or lower number is not automatically a better investment. Financial statement periods are not calendar-aligned across companies.

Reported performance

Financial trends

Reporting period
Financial history
Chart style
Comparison stocks

Financial statements load separately from the research page.

Market context

Valuation & price history

Adjusted closing price

Price history

Price history loads separately.

Earnings-multiple scenario

Illustrative price = your earnings-per-share assumption × your P/E assumption. This is not a price target or a complete valuation model.

Starting assumptions, when available, use provider forward estimates as of 2026-09-20. Negative earnings require a different valuation method. This calculation omits balance-sheet, dilution and execution risks.

THE RESEARCH RECORD

Research history for NEOG

All available reporting periods
Q4 FY20262026-08-01

Reported figures

Verify material figures against company filings. Market data and AI-assisted analysis may contain errors.